世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

農業生物学的製剤市場、2023-2035年:製品の種類(生物農薬/生物防除剤、生物肥料、生物刺激剤)、製品の供給源(微生物、植物抽出物、その他の供給源)、適用形態(葉面散布、種子処理、土壌処理、その他の適用方法)、処理される作物の種類(穀物および豆類、主要地域(北米、欧州、アジア太平洋、中東・北アフリカ、中南米):産業動向と世界予測


Agricultural Biologicals Market, 2023-2035: Distribution by Type of Product (Biopesticides / Biocontrols, Biofertilizers and Biostimulants), Source of Product (Microbes, Plant Extracts and Other Sources), Mode of Application (Foliar Sprays, Seed Treatments, Soil Treatments and Other Application Methods) Type of Crop Treated (Cereals and Pulses, Fruits and Nuts, Green Fodder, Vegetables and Tubers, Oilseeds, Industrial Crops, Textile Crops and Others) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts

世界の農業用生物製剤市場は、2023年までに137.6億米ドルに達し、2023年から2035年の予測期間中に年平均成長率9.98%で成長すると予測されている。 農業用生物製剤は農業用生物製剤とも呼ばれ、生物農薬、生物... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Roots Analysis
ルーツアナリシス
2023年9月19日 US$4,799
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
308 英語

 

サマリー

世界の農業用生物製剤市場は、2023年までに137.6億米ドルに達し、2023年から2035年の予測期間中に年平均成長率9.98%で成長すると予測されている。

農業用生物製剤は農業用生物製剤とも呼ばれ、生物農薬、生物肥料、生物刺激剤など幅広い品目をカバーしている。これらの製品は、微生物、植物抽出物、有益な昆虫、その他の有機物などの天然要素を原料としている。その主な目的は、土壌の肥沃度を高め、生物学的プロセスを刺激し、植物の成長をサポートすることである。特筆すべきは、生態系に有害な残留物を残さない、環境に優しいことである。また、化学農薬や化学肥料にありがちな、農家や消費者の健康への潜在的リスクの軽減にも役立つ。長年にわたる激しい農作業や化学農薬・化学肥料の過剰使用は、有益な微生物を減少させることで土壌の質に悪影響を及ぼしてきた。その結果、作物の健康が損なわれ、土壌の肥沃度が低下している。生物農薬、生物肥料、生物刺激剤を含む農業用生物製剤は、従来の化学物質投入への依存を減らすためにますます使用されるようになっている。

さらに、これらの生物製剤は、持続可能な農業や有機農業システムの基盤となっている。これらは、世界人口の拡大による食糧需要の増大に対応する上で、極めて重要な役割を果たしている。また、有機食品に対する消費者の嗜好に合致し、持続可能な農業を促進する。その結果、農業用生物学的製剤市場は予測期間中に大きな成長を遂げることが予想される。

レポート対象範囲
 本レポートでは、製品の種類、製品の供給源、適用形態、処理される作物の種類、主要地域など、さまざまなパラメータにわたって農業用生物製剤市場を調査している。
 市場成長に影響を与える要因(促進要因、阻害要因、機会、課題など)について分析を行っています。
 主要市場プレイヤーの競争環境に関する洞察とともに、市場環境における潜在的な利点と障壁の評価が提供される。
 5つの重要な地域に関する市場セグメントの収益予測を示しています。
 農業用生物製剤市場を調査するために採用した体系的な調査アプローチについて、調査結果の正確性と信頼性を確保することを目的とした方法論、前提条件、品質管理対策を包含する詳細な説明がなされています。
 為替変動、外国為替の影響、景気後退、インフレなどの歴史的動向や経済的影響について、農業用生物製剤市場との関連性を検証しています。
 簡潔な要約では、短期、中期、長期のタイムラインにわたる農業生物学的製剤市場の現状と予想される進化について、主要な調査結果と包括的な展望を提供している。
 様々な農業用生物製剤をその機能に基づいて説明し、農業分野における優位性を強調している。このセクションでは、機会、将来の見通し、およびそのような作物保護製品の必要性の増加について説明します。
 農業用生物製剤を提供する企業を、設立年、企業規模、本社所在地、提供する製品タイプ、製剤、用途、市場における重要性などのパラメータに基づいて徹底的に評価する。
 企業の競争力に関する包括的な分析では、経験や企業規模を含むサプライヤーの強みと、製品タイプ、作物の種類、供給源、用途、製剤を含む製品ポートフォリオの強みを考慮している。
 農業用生物製剤のトップ企業については、会社概要、財務実績(入手可能な場合)、製品ポートフォリオ、最近の開発状況、将来展望を含む詳細なプロフィールを掲載。
 2020年以降の販売契約、買収、製品開発提携、研究契約など、農業生物製剤企業間の提携を包括的にレビューしている。
 2019年以降に出願/付与された農業用生物製剤に関連する特許について、公開年、地域分布、主要企業、特許評価額を考慮した詳細な検証を行っている。これには、引用に基づく重要特許のベンチマークも含まれる。
 農業用生物製剤市場に影響を与える競争力について徹底的な評価を実施し、新規参入企業による脅威、開発企業とエンドユーザーの交渉力、代替製品、競合企業間の競争などを網羅する。
 詳細な分析により、農業用生物製剤市場の成長に影響を与える促進要因、阻害要因、機会、課題を特定。

主要市場企業
 AMVAC
 アンデルマット
 BASF SE
 バイエル
 バイオセーフ・システムズ
 ブラント
 Chr.Hansen
 サーティス・バイオロジカルズ
 コーテバ・アグリスサイエンス
 FBSciences
 グロウ・インディゴ
 コッパート・バイオロジカル・システムズ
 ラレマンド
 ニュートリテック・ソリューションズ
 ノボザイムズ
 PI インダストリーズ
 プロファーム
 SQM
 ストーラー
 シンジェンタAG
 UPL
 ベガラボ
 ヴァレント・バイオサイエンシズ
 ヴェルディジアン・ライフサイエンス

ページTOPに戻る


目次

1. PREFACE
1.1. Agricultural Biologicals Market Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Sustainable Agriculture
5.3. Introduction to Agricultural Biologicals
5.3.1. Types of Agricultural Biologicals
5.3.1.1. Biostimulants
5.3.1.2. Biopesticides / Biocontrols
5.3.1.3. Biofertilizers
5.3.2. Advantages of Agricultural Biologicals
5.4. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Agricultural Biologicals Manufacturers: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Year of Establishment and Company Size
6.2.4. Analysis by Location of Headquarters
6.2.5. Analysis by Company Size and Location of Headquarters
6.2.6. Analysis by Type of Product Offered
6.2.7. Analysis by Company Size and Type of Product Offered
6.2.8. Analysis by Source of Product Offered
6.2.9. Analysis by Type of Product Formulation
6.2.10. Analysis by Type of Crop Treated
6.2.11. Analysis by Mode of Application
6.2.12. Analysis by Number of Products Offered
6.2.13. Most Active Players: Analysis by Number of Products Offered
7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in North America
7.4.1 Very Small and Small Companies in North America
7.4.2. Mid-sized Companies in North America
7.4.3. Large and Very Large Companies in North America
7.5. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Europe
7.5.1. Very Small and Small Companies in Europe
7.5.2. Mid-sized Companies in Europe
7.5.3. Large and Very Large Companies in Europe
7.6. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Asia-Pacific and Rest of the World
7.6.1. Very Small and Small Companies in Asia-Pacific and Rest of the World
7.6.2. Mid-sized Companies in Asia-Pacific and Rest of the World
7.6.3. Large and Very Large Companies in Asia-Pacific and Rest of the World
7.7. Company Competitiveness Analysis: Other Agricultural Biologicals Manufacturers
8. COMPANY PROFILES
8.1. Chapter Overview
8.2. Leading Players in Agricultural Biologicals Market
8.2.1. Andermatt
8.2.1.1. Company Overview
8.2.1.2. Agricultural Biologicals Portfolio
8.2.1.3. Recent Developments and Future Outlook
8.2.2. Certis Biologicals
8.2.2.1. Company Overview
8.2.2.2. Agricultural Biologicals Portfolio
8.2.2.3. Recent Developments and Future Outlook
8.2.3. Corteva Agriscience
8.2.3.1. Company Overview
8.2.3.2. Financial Information
8.2.3.3. Agricultural Biologicals Portfolio
8.2.3.4. Recent Developments and Future Outlook
8.2.4. Nutri-Tech Solutions
8.2.4.1. Company Overview
8.2.4.2. Agricultural Biologicals Portfolio
8.2.4.3. Recent Developments and Future Outlook
8.2.5. Novozymes
8.2.5.1. Company Overview
8.2.5.2. Financial Information
8.2.5.3. Agricultural Biologicals Portfolio
8.2.5.4. Recent Developments and Future Outlook
8.2.6. ProFarm
8.2.6.1. Company Overview
8.2.6.2. Agricultural Biologicals Portfolio
8.2.6.3. Recent Developments and Future Outlook
8.2.7. SQM
8.2.7.1. Company Overview
8.2.7.2. Agricultural Biologicals Portfolio
8.2.7.3. Recent Developments and Future Outlook
8.2.8. UPL
8.2.8.1. Company Overview
8.2.8.2. Financial Information
8.2.8.3. Agricultural Biologicals Portfolio
8.2.8.4. Recent Developments and Future Outlook
8.2.9. Vegalab
8.2.9.1. Company Overview
8.2.9.2. Agricultural Biologicals Portfolio
8.2.9.3. Recent Developments and Future Outlook
8.3. Other Leading Players in Agricultural Biologicals Market
8.3.1. AMVAC
8.3.1.1. Company Overview
8.3.1.2. Agricultural Biologicals Portfolio
8.3.2. BASF
8.3.2.1. Company Overview
8.3.2.2. Agricultural Biologicals Portfolio
8.3.3. Bayer
8.3.3.1. Company Overview
8.3.3.2. Agricultural Biologicals Portfolio
8.3.4. BioSafe Systems
8.3.4.1. Company Overview
8.3.4.2. Agricultural Biologicals Portfolio
8.3.5. Brandt
8.3.5.1. Company Overview
8.3.5.2. Agricultural Biologicals Portfolio
8.3.6. Chr. Hansen
8.3.6.1. Company Overview
8.3.6.2. Agricultural Biologicals Portfolio
8.3.7. FBSciences
8.3.7.1. Company Overview
8.3.7.2. Agricultural Biologicals Portfolio
8.3.8. Grow Indigo
8.3.8.1. Company Overview
8.3.8.2. Agricultural Biologicals Portfolio
8.3.9. Koppert
8.3.9.1. Company Overview
8.3.9.2. Agricultural Biologicals Portfolio
8.3.10. Lallemand
8.3.10.1. Company Overview
8.3.10.2. Agricultural Biologicals Portfolio
8.3.11. PI Industries
8.3.11.1. Company Overview
8.3.11.2. Agricultural Biologicals Portfolio
8.3.12. Stoller
8.3.12.1. Company Overview
8.3.12.2. Agricultural Biologicals Portfolio
8.3.13. Syngenta
8.3.13.1. Company Overview
8.3.13.2. Agricultural Biologicals Portfolio
8.3.14. Valent Biosciences
8.3.14.1. Company Overview
8.3.14.2. Agricultural Biologicals Portfolio
8.3.15. Verdesian Life Sciences
8.3.15.1. Company Overview
8.3.15.2. Agricultural Biologicals Portfolio
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Agricultura Biologicals: Recent Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Partnership and Company Size
9.3.5. Analysis by Focus Area of Partnership
9.3.6. Analysis by Type of Partner
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8 Analysis by Geography
9.3.8.1. Local and International Agreements
9.3.8.2. Intracontinental and Intercontinental Agreements
10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Agricultural Biologicals: Patent Analysis
10.3.1. Analysis by Patent Publication Year
10.3.2. Analysis by Patent Application Year
10.3.3. Analysis of Granted Patents and Patent Applications by Publication Year
10.3.4. Analysis by Patent Jurisdiction
10.3.5. Analysis by CPC Symbols
10.3.6. Analysis by Type of Applicant
10.3.7. Leading Industry Players: Analysis by Number of Patents
10.3.8. Leading Non-Industry Players: Analysis by Number of Patents
10.3.9. Leading Individual Assignees: Analysis by Number of Patents
10.4. Agricultural Biologicals: Patent Benchmarking Analysis
10.4.1. Analysis by Patent Characteristics
10.5. Agricultural Biologicals: Patent Valuation
10.6. Leading Patents by Number of Citations
11. PORTER’S FIVE FORCES ANALYSIS
11.1. Chapter Overview
11.2. Methodology and Assumptions
11.3. Key Parameters
11.3.1. Threats of New Entrants
11.3.2. Bargaining Power of End-Users
11.3.3. Bargaining Power of Product Developers
11.3.4. Threats of Substitute Products
11.3.5. Rivalry Among Existing Competitors
11.4. Concluding Remarks
12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion
13. GLOBAL AGRICULTURAL BIOLOGICALS MARKET
13.1. Chapter Overview
13.2. Assumptions and Methodology
13.3. Global Agricultural Biologicals Market, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
13.3.1. Scenario Analysis
13.4. Key Market Segmentations
13.5. Dynamic Dashboard
14. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF PRODUCT
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Agricultural Biologicals Market: Distribution by Type of Product, 2019, 2023 and 2035 (USD Billion)
14.3.1. Biopesticides / Biocontrols Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
14.3.2. Biofertilizers Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
14.3.3. Biostimulants Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
14.4. Data Triangulation
14.4.1. Insights based on Primary Research
14.4.2. Insights based on Secondary Research
15. AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE OF PRODUCT
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Agricultural Biologicals Market: Distribution by Source of Product, 2019, 2023 and 2035 (USD Billion)
15.3.1. Agricultural Biologicals Market for Microbes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
15.3.2. Agricultural Biologicals Market for Plant Extracts: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
15.3.3. Agricultural Biologicals Market for Other Sources: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
15.4. Data Triangulation
15.4.1. Insights based on Primary Research
15.4.2. Insights based on Secondary Research
16. AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Agricultural Biologicals Market: Distribution by Mode of Application, 2019, 2023 and 2035 (USD Billion)
16.3.1. Agricultural Biologicals Market for Foliar Sprays: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.3.2. Agricultural Biologicals Market for Seed Treatments: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.3.3. Agricultural Biologicals Market for Soil Treatments: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.3.4. Agricultural Biologicals Market for Other Application Methods: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.4. Data Triangulation
16.4.1. Insights based on Primary Research
16.4.2. Insights based on Secondary Research
17. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF CROP TREATED
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Agricultural Biologicals Market: Distribution by Type of Crop Treated, 2019, 2023 and 2035 (USD Billion)
17.3.1. Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.3.2. Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.3.3. Agricultural Biologicals Market for Oilseeds: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.3.4. Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.3.5. Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.4. Data Triangulation
17.4.1. Insights based on Secondary Research
18. AGRICULTURAL BIOLOGICALS MARKET, BY GEOGRAPHY
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Agricultural Biologicals Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035 (USD Billion)
18.3.1. Agricultural Biologicals Market for North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.3.2. Agricultural Biologicals Market for Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.3.3. Agricultural Biologicals Market for Aisa-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.3.4. Agricultural Biologicals Market for Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.3.5. Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.4. Data Triangulation
18.4.1. Insights based on Primary Research
18.4.2. Insights based on Secondary Research
19. CONCLUSION
20. EXECUTIVE INSIGHTS
20.1. Chapter Overview
20.2. Vegalab
20.2.1. Company Snapshot
20.2.2. Interview Transcript: David Selakovic, President
20.3. Acadian Plant Health
20.3.1. Company Snapshot
20.3.2. Interview Transcript: Shannon Wentz, Global Director
20.4. Jiahe Biology
20.4.1. Company Snapshot
20.4.2. Interview Transcript: Zhange, Sales Representative
21. APPENDIX 1: TABULATED DATA
22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

ページTOPに戻る


 

Summary

The global agricultural biologics market is expected to reach USD 13.76 billion by 2023 anticipated to grow at a CAGR of 9.98% during the forecast period 2023-2035.

Agricultural biologicals, also referred to as agricultural biologics, cover a wide range of items like biopesticides, biofertilizers, and biostimulants. These products are sourced from natural elements such as microorganisms, plant extracts, beneficial insects, or other organic matter. Their main aim is to boost soil fertility, stimulate biological processes, and support plant growth. Notably, they are eco-friendly, leaving no harmful residues in ecosystems. They also help reduce potential risks to farmers' and consumers' health typically linked to chemical pesticides and fertilizers. Years of intense agricultural practices and excessive use of chemical pesticides and fertilizers have negatively affected soil quality by reducing beneficial microorganisms. This has led to compromised crop health and diminished soil fertility. Agricultural biologics, including biopesticides, biofertilizers, and biostimulants, are increasingly used to reduce dependence on traditional chemical inputs.

Furthermore, these biological products are fundamental to sustainable agriculture and organic farming systems. They play a crucial role in addressing the growing food demand due to the expanding global population. They also align with consumer preferences for organic food, promoting sustainable farming practices. Consequently, the agricultural biologicals market is expected to witness significant growth in the forecast period.

Report Coverage
 The report examines the agricultural biologics market across various parameters such as type of product, source of product, mode of application, type of crop treated and key geographical regions
 Analysis is conducted on factors influencing market growth, including drivers, restraints, opportunities, and challenges.
 Evaluation of potential advantages and barriers within the market landscape is provided, alongside insights into the competitive environment for leading market players.
 Revenue forecasts for market segments are presented concerning five significant regions.
 A detailed explanation is given regarding the systematic research approach employed to study the agricultural biologics market, encompassing methodologies, assumptions, and quality control measures aimed at ensuring precision and reliability of findings.
 Historical trends and economic influences such as currency fluctuations, foreign exchange impacts, recession, and inflation are examined in their relation to the agricultural biologics market.
 A concise summary offers major findings and an overarching perspective on the current status and anticipated evolution of the agricultural biologicals market across short, medium, and long-term timelines.
 Various agricultural biologics are described based on their functions, emphasizing their advantages in the agricultural sector. This section explores opportunities, future prospects, and the increasing necessity for such crop protection products.
 Companies offering agricultural biologics are thoroughly evaluated based on parameters like establishment year, company size, headquarters location, product types offered, formulations, applications, and their significance in the market.
 Comprehensive analysis of company competitiveness considers supplier strength, encompassing experience and company size, and product portfolio strength, including product types, crop variety, sources, applications, and formulations.
 Elaborate profiles are provided for top companies in agricultural biologics, featuring company overviews, financial performance (if available), product portfolios, recent developments, and future prospects.
 A comprehensive review is conducted on partnerships between agricultural biologics companies, encompassing distribution agreements, acquisitions, product development collaborations, research agreements, and more since 2020.
 In-depth examination of patents filed/granted related to agricultural biologics since 2019 is presented, considering publication year, geographical distribution, leading players, and patent valuation. This includes benchmarking of significant patents based on citations.
 Thorough assessment is performed on competitive forces impacting the agricultural biologicals market, covering threats from new entrants, bargaining power of developers and end-users, substitute products, and rivalry among competitors.
 Detailed analysis identifies drivers, restraints, opportunities, and challenges influencing the growth of the agricultural biologicals market.

Key Market Companies
 AMVAC
 Andermatt
 BASF SE
 Bayer AG
 BioSafe Systems
 Brandt
 Chr. Hansen
 Certis Biologicals
 Corteva Agriscience
 FBSciences
 Grow Indigo
 Koppert Biological Systems
 Lallemand
 Nutri-Tech Solutions
 Novozymes
 PI Industries
 ProFarm
 SQM
 Stoller
 Syngenta AG
 UPL
 Vegalab
 Valent Biosciences
 Verdisian Life Sciences



ページTOPに戻る


Table of Contents

1. PREFACE
1.1. Agricultural Biologicals Market Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Sustainable Agriculture
5.3. Introduction to Agricultural Biologicals
5.3.1. Types of Agricultural Biologicals
5.3.1.1. Biostimulants
5.3.1.2. Biopesticides / Biocontrols
5.3.1.3. Biofertilizers
5.3.2. Advantages of Agricultural Biologicals
5.4. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Agricultural Biologicals Manufacturers: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Year of Establishment and Company Size
6.2.4. Analysis by Location of Headquarters
6.2.5. Analysis by Company Size and Location of Headquarters
6.2.6. Analysis by Type of Product Offered
6.2.7. Analysis by Company Size and Type of Product Offered
6.2.8. Analysis by Source of Product Offered
6.2.9. Analysis by Type of Product Formulation
6.2.10. Analysis by Type of Crop Treated
6.2.11. Analysis by Mode of Application
6.2.12. Analysis by Number of Products Offered
6.2.13. Most Active Players: Analysis by Number of Products Offered
7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in North America
7.4.1 Very Small and Small Companies in North America
7.4.2. Mid-sized Companies in North America
7.4.3. Large and Very Large Companies in North America
7.5. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Europe
7.5.1. Very Small and Small Companies in Europe
7.5.2. Mid-sized Companies in Europe
7.5.3. Large and Very Large Companies in Europe
7.6. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Asia-Pacific and Rest of the World
7.6.1. Very Small and Small Companies in Asia-Pacific and Rest of the World
7.6.2. Mid-sized Companies in Asia-Pacific and Rest of the World
7.6.3. Large and Very Large Companies in Asia-Pacific and Rest of the World
7.7. Company Competitiveness Analysis: Other Agricultural Biologicals Manufacturers
8. COMPANY PROFILES
8.1. Chapter Overview
8.2. Leading Players in Agricultural Biologicals Market
8.2.1. Andermatt
8.2.1.1. Company Overview
8.2.1.2. Agricultural Biologicals Portfolio
8.2.1.3. Recent Developments and Future Outlook
8.2.2. Certis Biologicals
8.2.2.1. Company Overview
8.2.2.2. Agricultural Biologicals Portfolio
8.2.2.3. Recent Developments and Future Outlook
8.2.3. Corteva Agriscience
8.2.3.1. Company Overview
8.2.3.2. Financial Information
8.2.3.3. Agricultural Biologicals Portfolio
8.2.3.4. Recent Developments and Future Outlook
8.2.4. Nutri-Tech Solutions
8.2.4.1. Company Overview
8.2.4.2. Agricultural Biologicals Portfolio
8.2.4.3. Recent Developments and Future Outlook
8.2.5. Novozymes
8.2.5.1. Company Overview
8.2.5.2. Financial Information
8.2.5.3. Agricultural Biologicals Portfolio
8.2.5.4. Recent Developments and Future Outlook
8.2.6. ProFarm
8.2.6.1. Company Overview
8.2.6.2. Agricultural Biologicals Portfolio
8.2.6.3. Recent Developments and Future Outlook
8.2.7. SQM
8.2.7.1. Company Overview
8.2.7.2. Agricultural Biologicals Portfolio
8.2.7.3. Recent Developments and Future Outlook
8.2.8. UPL
8.2.8.1. Company Overview
8.2.8.2. Financial Information
8.2.8.3. Agricultural Biologicals Portfolio
8.2.8.4. Recent Developments and Future Outlook
8.2.9. Vegalab
8.2.9.1. Company Overview
8.2.9.2. Agricultural Biologicals Portfolio
8.2.9.3. Recent Developments and Future Outlook
8.3. Other Leading Players in Agricultural Biologicals Market
8.3.1. AMVAC
8.3.1.1. Company Overview
8.3.1.2. Agricultural Biologicals Portfolio
8.3.2. BASF
8.3.2.1. Company Overview
8.3.2.2. Agricultural Biologicals Portfolio
8.3.3. Bayer
8.3.3.1. Company Overview
8.3.3.2. Agricultural Biologicals Portfolio
8.3.4. BioSafe Systems
8.3.4.1. Company Overview
8.3.4.2. Agricultural Biologicals Portfolio
8.3.5. Brandt
8.3.5.1. Company Overview
8.3.5.2. Agricultural Biologicals Portfolio
8.3.6. Chr. Hansen
8.3.6.1. Company Overview
8.3.6.2. Agricultural Biologicals Portfolio
8.3.7. FBSciences
8.3.7.1. Company Overview
8.3.7.2. Agricultural Biologicals Portfolio
8.3.8. Grow Indigo
8.3.8.1. Company Overview
8.3.8.2. Agricultural Biologicals Portfolio
8.3.9. Koppert
8.3.9.1. Company Overview
8.3.9.2. Agricultural Biologicals Portfolio
8.3.10. Lallemand
8.3.10.1. Company Overview
8.3.10.2. Agricultural Biologicals Portfolio
8.3.11. PI Industries
8.3.11.1. Company Overview
8.3.11.2. Agricultural Biologicals Portfolio
8.3.12. Stoller
8.3.12.1. Company Overview
8.3.12.2. Agricultural Biologicals Portfolio
8.3.13. Syngenta
8.3.13.1. Company Overview
8.3.13.2. Agricultural Biologicals Portfolio
8.3.14. Valent Biosciences
8.3.14.1. Company Overview
8.3.14.2. Agricultural Biologicals Portfolio
8.3.15. Verdesian Life Sciences
8.3.15.1. Company Overview
8.3.15.2. Agricultural Biologicals Portfolio
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Agricultura Biologicals: Recent Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Partnership and Company Size
9.3.5. Analysis by Focus Area of Partnership
9.3.6. Analysis by Type of Partner
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8 Analysis by Geography
9.3.8.1. Local and International Agreements
9.3.8.2. Intracontinental and Intercontinental Agreements
10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Agricultural Biologicals: Patent Analysis
10.3.1. Analysis by Patent Publication Year
10.3.2. Analysis by Patent Application Year
10.3.3. Analysis of Granted Patents and Patent Applications by Publication Year
10.3.4. Analysis by Patent Jurisdiction
10.3.5. Analysis by CPC Symbols
10.3.6. Analysis by Type of Applicant
10.3.7. Leading Industry Players: Analysis by Number of Patents
10.3.8. Leading Non-Industry Players: Analysis by Number of Patents
10.3.9. Leading Individual Assignees: Analysis by Number of Patents
10.4. Agricultural Biologicals: Patent Benchmarking Analysis
10.4.1. Analysis by Patent Characteristics
10.5. Agricultural Biologicals: Patent Valuation
10.6. Leading Patents by Number of Citations
11. PORTER’S FIVE FORCES ANALYSIS
11.1. Chapter Overview
11.2. Methodology and Assumptions
11.3. Key Parameters
11.3.1. Threats of New Entrants
11.3.2. Bargaining Power of End-Users
11.3.3. Bargaining Power of Product Developers
11.3.4. Threats of Substitute Products
11.3.5. Rivalry Among Existing Competitors
11.4. Concluding Remarks
12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion
13. GLOBAL AGRICULTURAL BIOLOGICALS MARKET
13.1. Chapter Overview
13.2. Assumptions and Methodology
13.3. Global Agricultural Biologicals Market, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
13.3.1. Scenario Analysis
13.4. Key Market Segmentations
13.5. Dynamic Dashboard
14. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF PRODUCT
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Agricultural Biologicals Market: Distribution by Type of Product, 2019, 2023 and 2035 (USD Billion)
14.3.1. Biopesticides / Biocontrols Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
14.3.2. Biofertilizers Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
14.3.3. Biostimulants Market: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
14.4. Data Triangulation
14.4.1. Insights based on Primary Research
14.4.2. Insights based on Secondary Research
15. AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE OF PRODUCT
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Agricultural Biologicals Market: Distribution by Source of Product, 2019, 2023 and 2035 (USD Billion)
15.3.1. Agricultural Biologicals Market for Microbes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
15.3.2. Agricultural Biologicals Market for Plant Extracts: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
15.3.3. Agricultural Biologicals Market for Other Sources: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
15.4. Data Triangulation
15.4.1. Insights based on Primary Research
15.4.2. Insights based on Secondary Research
16. AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Agricultural Biologicals Market: Distribution by Mode of Application, 2019, 2023 and 2035 (USD Billion)
16.3.1. Agricultural Biologicals Market for Foliar Sprays: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.3.2. Agricultural Biologicals Market for Seed Treatments: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.3.3. Agricultural Biologicals Market for Soil Treatments: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.3.4. Agricultural Biologicals Market for Other Application Methods: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
16.4. Data Triangulation
16.4.1. Insights based on Primary Research
16.4.2. Insights based on Secondary Research
17. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF CROP TREATED
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Agricultural Biologicals Market: Distribution by Type of Crop Treated, 2019, 2023 and 2035 (USD Billion)
17.3.1. Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.3.2. Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.3.3. Agricultural Biologicals Market for Oilseeds: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.3.4. Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.3.5. Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
17.4. Data Triangulation
17.4.1. Insights based on Secondary Research
18. AGRICULTURAL BIOLOGICALS MARKET, BY GEOGRAPHY
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Agricultural Biologicals Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035 (USD Billion)
18.3.1. Agricultural Biologicals Market for North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.3.2. Agricultural Biologicals Market for Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.3.3. Agricultural Biologicals Market for Aisa-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.3.4. Agricultural Biologicals Market for Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.3.5. Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
18.4. Data Triangulation
18.4.1. Insights based on Primary Research
18.4.2. Insights based on Secondary Research
19. CONCLUSION
20. EXECUTIVE INSIGHTS
20.1. Chapter Overview
20.2. Vegalab
20.2.1. Company Snapshot
20.2.2. Interview Transcript: David Selakovic, President
20.3. Acadian Plant Health
20.3.1. Company Snapshot
20.3.2. Interview Transcript: Shannon Wentz, Global Director
20.4. Jiahe Biology
20.4.1. Company Snapshot
20.4.2. Interview Transcript: Zhange, Sales Representative
21. APPENDIX 1: TABULATED DATA
22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Roots Analysis社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Roots Analysis社はどのような調査会社ですか?


Roots Analysisは2013年設立の医薬品・医療機器が専門の調査会社です。 医薬品の製造委託や創薬のデジタル化など、最新の医薬業界の分析を行っています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る